Trastuzumab deruxtecan shows substantial anti-cancer activity in brain metastases in patients with HER2-positive breast cancer in a major...
Vous n'êtes pas connecté
TetRS is a rapid genotyping test that identifies key mutations in brain tumors using cerebrospinal fluid samples obtained through lumbar puncture.
Trastuzumab deruxtecan shows substantial anti-cancer activity in brain metastases in patients with HER2-positive breast cancer in a major...
A recent study from Flinders University in Australia has made a significant discovery that could change the way we understand cancer. This research...
Discover how a new ultrasound test can detect 96% of ovarian tumors in postmenopausal women, outperforming the UK's current standard of care.
Early detection is key in managing and treating cancer and therefore it's important not to ignore the early warning signs. An oncologist shares his...
Antidepressant vortioxetine shows potential in treating brain tumors, offering new hope in cancer therapy by targeting tumor growth and enhancing...
A multi-institutional clinical trial led by Weill Cornell Medicine and NewYork-Presbyterian investigators showed that a newer technique for collecting...
Diffuse midline glioma (DMG) is a highly aggressive and fatal pediatric high-grade glioma that primarily affects critical regions of the central...
In a world first, veterinary scientists at Université de Montréal have found a way to scan the brains of cats while they’re awake, using...
UK's current standard of care test for bmedlinkovarian cancer/medlink shall be replaced with an ultrasound test that can detect 96% of ovarian...
A study from Huntsman Cancer Institute at the University of Utah (the U) and NYU Langone Perlmutter Cancer Center, USA, found that a specialised...